Narrow search
Showing 1 - 4 of 4
Cover Image
Biosimilar Versus Patented Erythropoietins: Learning from 5 Years of European and Japanese Experience
Bocquet, François; Paubel, Pascal; Fusier, Isabelle; … - Université Paris-Dauphine (Paris IX) - 2015
retail/hospital distribution mix, national incentives to use biosimilars and BIOSIM-EPO/REF price differences. IMS Health …
Persistent link: https://www.econbiz.de/10011228183
Cover Image
Public regulation of the cancer drugs market in French hospitals
Le Pen, Claude; Rieu, C.; Bensadon, M.; … - Université Paris-Dauphine (Paris IX) - 2009
Persistent link: https://www.econbiz.de/10010706533
Cover Image
Temporary use authorizations : the economic and clinical future of drugs used in the french compassionate program
Sinègre, Martine; Le Pen, Claude; Parent de Curzon, Olivier - Université Paris-Dauphine (Paris IX) - 2011
Persistent link: https://www.econbiz.de/10010708345
Cover Image
Biosimilar Granulocyte Colony-Stimulating Factor Uptakes in the EU-5 Markets: A Descriptive Analysis
Bocquet, François; Paubel, Pascal; Fusier, Isabelle; … - Université Paris-Dauphine (Paris IX) - 2014
-CSF categories were provided by IMS Health. Volumes were calculated in defined daily doses (DDD) and prices in Euros per DDD. In the …
Persistent link: https://www.econbiz.de/10011072825